PureTech publishes Phase 2b trial results for IPF drug candidate.
Share this article
Earnings
Score 25
Neutral
PureTech publishes Phase 2b trial results for IPF drug candidate
Apr 02, 2026 12:25 UTC
PTI
Short term
Related Articles
Score 35
Here are the major earnings after the close Thursday
Apr 02, 14:00
Score 75
Bearish
Tesla’s stock falls as new numbers show weakness in both the EV and energy businesses
Apr 02, 13:58
Score 25
DynaResource reports Q4 results
Apr 02, 13:41
Score 25
Bearish
Dogness GAAP EPS of -$0.29, revenue of $7.7M
Apr 02, 13:36
Stay Ahead of the Markets
Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.